Application no. and date | 08008814.9 (espacenet) (Federated) (European Patent Register), 20041116 | Patent/reg. no. and date | DK/EP 1983000, 20150902 | Publication date | 20081022 | Priority no. and date | GB 0327181, 20031121, GB 0417115, 20040730 | EP pub. no. and date |
EP 1983000 20081022 | Effective date | | Applicant/owner | UCB Biopharma SRL, Allée de la Recherche 60
1070 Brussels, BE | Applicant ref. no. | 159229 | Inventor | RAPECKI, Stephen Edward, UCB Celltech 208 Bath Road
Slough Berkshire SL1 3WE, GB, Christie, Mark Ian, UCB Celltech 208 Bath Road
Slough Berkshire SL1 3WE, GB, Mead, Richard James, UCB Celltech 208 Bath Road
Slough Berkshire SL1 3WE, GB, Robinson, Martyn Kim, UCB Celltech 208 Bath Road
Slough Berkshire SL1 3WE, GB | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 38/17 (2006.01) , A61K 39/395 (2006.01) , A61K 47/48 (2006.01) , A61P 37/00 (2006.01) , C07K 16/24 (2006.01) , C07K 16/28 (2006.01) | Title | Fremgangsmåde til behandling af multipel sklerose ved inhibering af IL-17-aktivitet | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|